×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Surface Plasmon Resonance Market

ID: MRFR/CnM/19101-HCR
111 Pages
Chitranshi Jaiswal
October 2025

US Surface Plasmon Resonance Market Research Report: By Product Type (Imaging System, Sensor System, Reagents), By Application (Drug Discovery, Material Science, Biosensors) and By End User (Academic & Research Institutes, Food & Beverage Industry, Biopharmaceutical Companies, CROs, Others) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Surface Plasmon Resonance Market
 Infographic
Purchase Options

US Surface Plasmon Resonance Market Summary

As per Market Research Future analysis, the US surface plasmon-resonance market size was estimated at 203.05 USD Million in 2024. The US surface plasmon-resonance market is projected to grow from 216.86 USD Million in 2025 to 418.79 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The US surface plasmon-resonance market is experiencing robust growth driven by technological advancements and increased adoption in healthcare.

  • Technological advancements are enhancing the capabilities of surface plasmon-resonance systems, leading to improved accuracy and efficiency.
  • The healthcare segment is the largest, with a notable increase in the adoption of surface plasmon-resonance for diagnostic applications.
  • Research and development initiatives are fostering innovation, making the market more competitive and dynamic.
  • Growing demand for biosensors and rising investment in nanotechnology are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 203.05 (USD Million)
2035 Market Size 418.79 (USD Million)
CAGR (2025 - 2035) 6.8%

Major Players

Biacore (SE), Horiba (JP), Reichert Technologies (US), SensiQ Technologies (US), Parker Hannifin (US), JPK Instruments (DE), Malvern Panalytical (GB), Nanonics Imaging (IL)

US Surface Plasmon Resonance Market Trends

The surface plasmon-resonance market is currently experiencing notable growth, driven by advancements in biosensing technologies and increasing demand for rapid and accurate diagnostic tools. This market is characterized by its application in various fields, including pharmaceuticals, biotechnology, and environmental monitoring. The integration of surface plasmon resonance in research laboratories and clinical settings appears to enhance the efficiency of biomolecular interactions, thereby facilitating drug discovery and development processes. Furthermore, the rising prevalence of chronic diseases necessitates innovative diagnostic solutions, which may further propel the adoption of surface plasmon-resonance systems. In addition, the ongoing research and development efforts in nanotechnology and materials science are likely to contribute to the evolution of the surface plasmon-resonance market. Enhanced sensitivity and specificity of detection methods are anticipated as new materials and techniques are introduced. Moreover, collaborations between academic institutions and industry players may foster innovation, leading to the emergence of novel applications. As the market continues to expand, it seems poised to play a crucial role in advancing healthcare and environmental monitoring solutions, ultimately improving patient outcomes and safety.

Technological Advancements

Recent innovations in sensor technology are enhancing the capabilities of surface plasmon-resonance systems. These advancements may lead to improved sensitivity and faster detection times, making them more appealing for various applications in diagnostics and research.

Increased Adoption in Healthcare

The growing emphasis on personalized medicine and rapid diagnostics is driving the adoption of surface plasmon-resonance systems in healthcare settings. This trend suggests a shift towards more efficient and accurate testing methods, which could transform patient care.

Research and Development Initiatives

Ongoing research initiatives focused on enhancing the functionality of surface plasmon-resonance technology are likely to yield new applications. These efforts may result in innovative solutions that address current limitations and expand the market's reach.

Market Segment Insights

By Product Type: Imaging System (Largest) vs. Sensor System (Fastest-Growing)

In the US surface plasmon-resonance market, the product type segmentation showcases Imaging Systems as the largest contributor, capturing a significant share of the market due to their advanced capabilities in high-resolution imaging techniques. Sensor Systems follow closely, recognized for their growing adoption in various applications, contributing to a dynamic competition landscape. Reagents, while important, are positioned as essential supportive products that complement both Imaging and Sensor Systems in practical applications. Growth trends indicate a shift towards more sophisticated Sensor Systems, which are rapidly gaining traction as research institutions and laboratories seek enhanced performance and accuracy in their experiments. This shift is driven by technological advancements, increasing demand for real-time monitoring solutions, and the expansion of research activities in biomedicine and environmental sectors. The Imaging Systems segment, while still dominant, is witnessing competition from innovative sensor technologies that promise faster results and improved user experiences.

Imaging System (Dominant) vs. Sensor System (Emerging)

The Imaging System segment stands out as a dominant force in the US surface plasmon-resonance market, characterized by its ability to provide precise and high-quality imaging for molecular and cellular analysis. This segment leverages cutting-edge technologies to deliver significant insights, making it invaluable for research and diagnostic applications. In contrast, the Sensor System segment is emerging rapidly, driven by increasing interest in miniaturized and user-friendly devices. These sensors are designed to enhance the efficiency of detection processes, offering flexible solutions tailored to various laboratory needs. Both segments are crucial to the market, with Imaging Systems leading in established use cases while Sensor Systems show promise for future growth through innovation and integration with digital tools.

By Application Type: Drug Discovery (Largest) vs. Biosensors (Fastest-Growing)

In the US surface plasmon-resonance market, the application type segment showcases a diverse distribution of market share. Drug Discovery holds the position of the largest segment, attributed to its significant use in analyzing biomolecular interactions relevant to pharmaceuticals. Material Science and Biosensors follow, with the latter gaining traction due to the increasing development of diagnostic tools and environmental sensors. Growth trends indicate a robust expansion for the Biosensors segment, driven by innovation in nanotechnology and increased demand for quick diagnostic solutions. Additionally, advancements in platform technologies and applications in personalized medicine are spurring interest in Drug Discovery. The convergence of these trends suggests a dynamic landscape where established segments evolve while emerging ones gain momentum.

Drug Discovery (Dominant) vs. Biosensors (Emerging)

The Drug Discovery segment in the US surface plasmon-resonance market is characterized by its extensive application in preclinical and clinical research, serving as a critical tool for pharmaceutical companies. Dominated by established players, this segment benefits from a resilient infrastructure and ongoing innovations. In contrast, the Biosensors segment is emerging rapidly, thanks to advancements in smart sensors capable of real-time analysis and a greater focus on health monitoring solutions. As regulatory frameworks evolve and technology becomes more accessible, both segments are expected to witness continued evolution, with Drug Discovery maintaining its dominance while Biosensors expands its footprint in diverse applications.

By End User: Biopharmaceutical Companies (Largest) vs. Academic & Research Institutes (Fastest-Growing)

In the US surface plasmon-resonance market, the distribution of market share among different end users reveals that biopharmaceutical companies hold the largest share, reflecting their significant investments in advanced biosensing technologies for drug discovery and development. Conversely, academic and research institutes are gaining traction, capturing a growing proportion of the market as they seek innovative analytical tools to support their research activities. The growth trends within this segment are notably influenced by increasing research and development activities, coupled with the rising demand for rapid and accurate analytical techniques. Biopharmaceutical companies are driving market expansion through their focus on personalized medicine and biologics, while academic institutions are benefiting from grants and collaborations that enhance their access to cutting-edge surface plasmon-resonance technologies.

Biopharmaceutical Companies (Dominant) vs. Academic & Research Institutes (Emerging)

Biopharmaceutical companies are currently the dominant players in the US surface plasmon-resonance market, leveraging these technologies for their ability to provide real-time insights into molecular interactions, which is critical for drug formulation and development. Their investment in high-throughput screening and biomolecular analysis positions them at the forefront of innovation. On the other hand, academic and research institutes, although classified as emerging players, are rapidly increasing their utilization of these technologies. They are exploring surface plasmon-resonance systems for various applications, including fundamental biological research and the development of new analytical methods. This growing interest is driven by the need for precise and sensitive detection capabilities, which are essential for advancing scientific knowledge and improving health outcomes.

Get more detailed insights about US Surface Plasmon Resonance Market

Key Players and Competitive Insights

The surface plasmon-resonance market exhibits a dynamic competitive landscape characterized by rapid technological advancements and increasing demand for biosensing applications. Key players such as Biacore (SE), Reichert Technologies (US), and SensiQ Technologies (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Biacore (SE) focuses on expanding its product portfolio through continuous R&D, while Reichert Technologies (US) emphasizes customer-centric solutions and service excellence. SensiQ Technologies (US) appears to be investing in digital transformation initiatives to streamline operations and improve customer engagement, collectively shaping a competitive environment that prioritizes technological prowess and customer satisfaction.

The market structure is moderately fragmented, with several players vying for market share through localized manufacturing and optimized supply chains. This fragmentation allows for diverse offerings, catering to various customer needs across sectors such as pharmaceuticals and biotechnology. The collective influence of these key players fosters a competitive atmosphere where innovation and operational efficiency are paramount, driving growth and market penetration.

In October 2025, Biacore (SE) announced a strategic partnership with a leading biotechnology firm to co-develop advanced biosensors aimed at enhancing drug discovery processes. This collaboration is expected to leverage Biacore's expertise in surface plasmon resonance technology, potentially accelerating the development of novel therapeutics. Such strategic alliances not only bolster Biacore's innovation capabilities but also position it favorably within the competitive landscape.

In September 2025, Reichert Technologies (US) launched a new line of surface plasmon resonance instruments designed for high-throughput applications in academic research. This product introduction reflects the company's commitment to meeting the evolving needs of researchers, thereby enhancing its competitive edge. By focusing on high-throughput capabilities, Reichert Technologies (US) aims to capture a larger share of the academic market, which is increasingly demanding efficient and reliable analytical tools.

In August 2025, SensiQ Technologies (US) unveiled a cloud-based platform that integrates AI-driven analytics with its surface plasmon resonance systems. This innovative approach not only enhances data interpretation but also streamlines workflows for researchers. The integration of AI signifies a shift towards more intelligent and automated solutions, positioning SensiQ Technologies (US) as a forward-thinking player in the market.

As of November 2025, current trends in the surface plasmon-resonance market indicate a strong emphasis on digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise for enhanced innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, supply chain reliability, and sustainable practices, underscoring the importance of adaptability in a rapidly changing market.

Key Companies in the US Surface Plasmon Resonance Market market include

Industry Developments

Recent developments in the US Surface Plasmon Resonance Market show a significant interest in innovative technologies and applications, particularly within the pharmaceutical and biotechnology sectors. Companies like Malvern Panalytical and GE Healthcare are expanding their portfolios, enhancing capabilities in biosensing technologies crucial for drug discovery and diagnostics.

As of October 2023, the US market has seen an increase in investments, with PerkinElmer reporting growth driven by advancements in their SPR products. In terms of mergers and acquisitions, Bruker acquired a biosensor company in June 2023, aiming to enhance its offerings in the SPR field, which was covered by multiple reliable sources.

Additionally, Agilent Technologies has formed strategic partnerships to integrate advanced sensors for real-time analysis, fostering innovation in research applications. The US government has emphasized the importance of scientific research funding, impacting growth in the SPR technology by allocating federal resources to research, thereby driving advancements.

The growing use of Surface Plasmon Resonance technology across various applications is expected to further elevate the market's valuation, contributing to technological adoption and competitive dynamics in the industry.

Future Outlook

US Surface Plasmon Resonance Market Future Outlook

The surface plasmon-resonance market is projected to grow at a 6.8% CAGR from 2024 to 2035, driven by advancements in biosensing technologies and increasing demand in pharmaceuticals.

New opportunities lie in:

  • Development of portable SPR devices for point-of-care diagnostics.
  • Integration of AI algorithms for enhanced data analysis in SPR systems.
  • Expansion into emerging markets with tailored SPR solutions for local industries.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic expansion.

Market Segmentation

US Surface Plasmon Resonance Market End User Outlook

  • Academic & Research Institutes
  • Food & Beverage Industry
  • Biopharmaceutical Companies
  • CROs
  • Others

US Surface Plasmon Resonance Market Product Type Outlook

  • Imaging System
  • Sensor System
  • Reagents

US Surface Plasmon Resonance Market Application Type Outlook

  • Drug Discovery
  • Material Science
  • Biosensors

Report Scope

MARKET SIZE 2024203.05(USD Million)
MARKET SIZE 2025216.86(USD Million)
MARKET SIZE 2035418.79(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)6.8% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled["Biacore (SE)", "Horiba (JP)", "Reichert Technologies (US)", "SensiQ Technologies (US)", "Parker Hannifin (US)", "JPK Instruments (DE)", "Malvern Panalytical (GB)", "Nanonics Imaging (IL)"]
Segments CoveredProduct Type, Application Type, End User
Key Market OpportunitiesAdvancements in biosensing applications drive growth in the surface plasmon-resonance market.
Key Market DynamicsTechnological advancements drive innovation in surface plasmon-resonance applications, enhancing competitive dynamics and market growth.
Countries CoveredUS

Leave a Comment

FAQs

What is the projected market size of the US Surface Plasmon Resonance Market by 2024?

The US Surface Plasmon Resonance Market is expected to be valued at 156.25 million USD in 2024.

What is the expected market size for the US Surface Plasmon Resonance Market by 2035?

By 2035, the market is anticipated to reach a value of 362.5 million USD.

What is the expected compound annual growth rate (CAGR) for the US Surface Plasmon Resonance Market from 2025 to 2035?

The market is expected to grow at a CAGR of 7.951% during the period from 2025 to 2035.

Which product segment is projected to dominate the US Surface Plasmon Resonance Market by 2035?

The Sensor System segment is expected to dominate, projected to reach 150 million USD by 2035.

What is the expected market value for the Imaging System segment by 2035?

The Imaging System segment is projected to be valued at 104 million USD by 2035.

What are some key players in the US Surface Plasmon Resonance Market?

Major players include Malvern Panalytical, Parker Hannifin, GE Healthcare, and Thermo Fisher Scientific.

What is the market value of the Reagents segment in 2024?

In 2024, the Reagents segment is expected to be valued at 46.25 million USD.

How are current industry trends influencing the US Surface Plasmon Resonance Market?

Emerging trends include advancements in sensor technologies and increased demand for diagnostic applications.

What are the key growth drivers for the US Surface Plasmon Resonance Market?

Growing applications in biosensing and diagnostics are primary growth drivers for the market.

Is there a significant impact of regional dynamics on the US Surface Plasmon Resonance Market growth?

Yes, regional innovations and healthcare investments significantly influence the growth of the market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions